Simple high performance liquid chromatographic assay for mycophenolic acid in renal transplant patients

被引:22
作者
Elbarbry, Fawzy A. [1 ]
Shoker, Ahmed
机构
[1] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK S7N 5C9, Canada
[2] Univ Saskatchewan, Dept Med, Saskatoon, SK S7N 5C9, Canada
关键词
renal transplant; mycophenolic acid; HPLC; validation;
D O I
10.1016/j.jpba.2006.08.012
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A selective and highly accurate HPLC-UV method is described to determine plasma concentrations of mycophenolic acid (MPA), the active metabolite of the prodrugs Cellcept (R) and Myfortic (R). The method is simple and utilizes acidification of plasma and protein precipitation step using a mixture of acetonitrile and phosphate buffer (pH 3). Following vortex mixing and centrifugation, the supernatant (50 mu L) was injected onto a Zorbax Eclipse XDB C-18 column (150 mm x 4.6 mm I.D., 5 mu m particle size). A mobile phase composed of acetonitrile and 0.1 M phosphate buffer, pH 3 (43:57) delivered at 1.0 mL/min produced peaks for MPA and the internal standard (Naproxen) in < 7 min. Calibration curves were linear (r(2) > 0.994) from 1.0-40 mu g/mL with intra- and inter-day precision < 15% and accuracy > 95%. The method's improved sensitivity (LOQ = 1.0 mu g/mL) and minimal sample processing allowed rapid monitoring of MPA in human plasma. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:788 / 792
页数:5
相关论文
共 22 条
[1]  
BARKOZI M, 2005, DARU, V13, P120
[2]   HPLC determination of mycophenolic acid and mycophenolic acid glucuronide in human plasma with hybrid material [J].
Bolon, M ;
Jeanpierre, L ;
El Barkil, M ;
Chelbi, K ;
Sauviat, M ;
Boulieu, R .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 36 (03) :649-651
[3]   Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: Results of a 1-year study [J].
Budde, K ;
Curtis, J ;
Knoll, G ;
Chan, L ;
Neumayer, HH ;
Seifu, Y ;
Hall, M .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (02) :237-243
[4]   Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration [J].
Bullingham, R ;
Monroe, S ;
Nicholls, A ;
Hale, M .
JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (04) :315-324
[5]   Mycophenolate mofetil - A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation [J].
Fulton, B ;
Markham, A .
DRUGS, 1996, 51 (02) :278-298
[6]   Pharmacokinetics of mycophenolic acid associated with calcineurin inhibitors: Long-term monitoring in stable lung recipients with and without cystic fibrosis [J].
Gerbase, MW ;
Fathi, M ;
Spiliopoulos, A ;
Rochat, T ;
Nicod, LP .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2003, 22 (05) :587-590
[7]   Pre-transplant inosine monophosphate dehydrogenase activity is associated with clinical outcome after renal transplantation [J].
Glander, P ;
Hambach, P ;
Braun, KP ;
Fritsche, L ;
Giessing, M ;
Mai, I ;
Einecke, G ;
Waiser, J ;
Neumayer, HH ;
Budde, K .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (12) :2045-2051
[8]   Analytic validation of the enzyme multiplied immunoassay technique for the determination of mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatographic assay [J].
Hosotsubo, H ;
Takahara, S ;
Imamura, R ;
Kyakuno, M ;
Tanaka, T ;
Yazawa, K ;
Hanafusa, T ;
Matsumiya, K ;
Nonomura, N ;
Okuyama, A ;
Sugimoto, H .
THERAPEUTIC DRUG MONITORING, 2001, 23 (06) :669-674
[9]   Analysis of mycophenolic acid in saliva using liquid chromatography tandem mass spectrometry [J].
Mendonza, Anisha E. ;
Gohh, Reginald Y. ;
Akhlaghi, Fatemeh .
THERAPEUTIC DRUG MONITORING, 2006, 28 (03) :402-406
[10]   Pharmacokinetics and pharmaco dynamics of low dose mycophenolate mofetil in HIV-infected patients treated with abacavir, efavirenz and nelfinavir [J].
Millán, O ;
Brunet, M ;
Martorell, J ;
García, F ;
Vidal, E ;
Rojo, I ;
Plana, M ;
Gallart, T ;
Pumarola, T ;
Miró, JM ;
Gatell, JM .
CLINICAL PHARMACOKINETICS, 2005, 44 (05) :525-538